These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 15258259)

  • 1. Silencing the formylpeptide receptor FPR by short-interfering RNA.
    Le Y; Iribarren P; Zhou Y; Gong W; Hu J; Zhang X; Wang JM
    Mol Pharmacol; 2004 Oct; 66(4):1022-8. PubMed ID: 15258259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formylpeptide receptor FPR and the rapid growth of malignant human gliomas.
    Zhou Y; Bian X; Le Y; Gong W; Hu J; Zhang X; Wang L; Iribarren P; Salcedo R; Howard OM; Farrar W; Wang JM
    J Natl Cancer Inst; 2005 Jun; 97(11):823-35. PubMed ID: 15928303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Activation of formylpeptide receptor in human malignant glioma cells and its effects on cell proliferation and production of angiogenic factors].
    Yao XH; Bian XW; Ping YF; Chen JH; Wang QL; Jiang XF
    Ai Zheng; 2007 Mar; 26(3):241-6. PubMed ID: 17355784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nordy, a synthetic lipoxygenase inhibitor, inhibits the expression of formylpeptide receptor and induces differentiation of malignant glioma cells.
    Chen JH; Bian XW; Yao XH; Gong W; Hu J; Chen K; Iribarren P; Zhao W; Zhou XD
    Biochem Biophys Res Commun; 2006 Apr; 342(4):1368-74. PubMed ID: 16516855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nordy inhibits cell proliferation and angiogenic factor production of malignant human glioma cells mediated by formylpeptide receptor].
    Yao XH; Ping YF; Bian XW; Chen JH; Wang QL; Jiang XF
    Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(7):479-84. PubMed ID: 17459229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of nordy on FPR function of malignant human glioma cell line U87].
    Chen JH; Bian XW; Yao XH; Yang SX; Xu CR; Zhou XD; Ping YF
    Yao Xue Xue Bao; 2007 Mar; 42(3):257-62. PubMed ID: 17520823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of Phospholipase D 1 and 2 in the subcellular localization and activity of formyl-peptide-receptors in the human colonic cell line HT29.
    Brandenburg LO; Seyferth S; Wruck CJ; Koch T; Rosenstiel P; Lucius R; Pufe T
    Mol Membr Biol; 2009 Aug; 26(5):371-83. PubMed ID: 19707939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulating FPR restrains xenograft tumors by impairing the angiogenic potential and invasive capability of malignant glioma cells.
    Chen DL; Ping YF; Yu SC; Chen JH; Yao XH; Jiang XF; Zhang HR; Wang QL; Bian XW
    Biochem Biophys Res Commun; 2009 Apr; 381(3):448-52. PubMed ID: 19233142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human malignant glioma cells expressing functional formylpeptide receptor recruit endothelial progenitor cells for neovascularization.
    Xu CP; Zhang HR; Chen FL; Yao XH; Liang ZQ; Zhang R; Cui Y; Qian C; Bian XW
    Int Immunopharmacol; 2010 Dec; 10(12):1602-7. PubMed ID: 20933627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A homolog of formyl peptide receptor-like 1 (FPRL1) inhibitor from Staphylococcus aureus (FPRL1 inhibitory protein) that inhibits FPRL1 and FPR.
    Prat C; Haas PJ; Bestebroer J; de Haas CJ; van Strijp JA; van Kessel KP
    J Immunol; 2009 Nov; 183(10):6569-78. PubMed ID: 19846866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil NADPH-oxidase activation by an annexin AI peptide is transduced by the formyl peptide receptor (FPR), whereas an inhibitory signal is generated independently of the FPR family receptors.
    Karlsson J; Fu H; Boulay F; Dahlgren C; Hellstrand K; Movitz C
    J Leukoc Biol; 2005 Sep; 78(3):762-71. PubMed ID: 15951351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The two neutrophil members of the formylpeptide receptor family activate the NADPH-oxidase through signals that differ in sensitivity to a gelsolin derived phosphoinositide-binding peptide.
    Fu H; Björkman L; Janmey P; Karlsson A; Karlsson J; Movitz C; Dahlgren C
    BMC Cell Biol; 2004 Dec; 5(1):50. PubMed ID: 15625007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibition of invasive and chemotactic abilities of SKOV3 cells by human epithelial growth receptor-2 small interfering RNA].
    Zhang SL; Lu YM; Meng LR; Zhao YY
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):48-53. PubMed ID: 17331422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibiting the growth of malignant melanoma by blocking the expression of vascular endothelial growth factor using an RNA interference approach.
    Tao J; Tu YT; Huang CZ; Feng AP; Wu Q; Lian YJ; Zhang LX; Zhang XP; Shen GX
    Br J Dermatol; 2005 Oct; 153(4):715-24. PubMed ID: 16181451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. House dust mite allergen activates human eosinophils via formyl peptide receptor and formyl peptide receptor-like 1.
    Svensson L; Redvall E; Björn C; Karlsson J; Bergin AM; Rabiet MJ; Dahlgren C; Wennerås C
    Eur J Immunol; 2007 Jul; 37(7):1966-77. PubMed ID: 17559171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of EDAG expression by retrovirus-mediated small interfering RNA inhibits the growth and IL-8 production of leukemia cells.
    Ling B; Zhou Y; Feng D; Shen G; Gao T; Shi Y; Wei H; Tian Z
    Oncol Rep; 2007 Sep; 18(3):659-64. PubMed ID: 17671716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of functional domains in the formyl peptide receptor-like 1 for agonist-induced cell chemotaxis.
    Le Y; Ye RD; Gong W; Li J; Iribarren P; Wang JM
    FEBS J; 2005 Feb; 272(3):769-78. PubMed ID: 15670157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis.
    Edovitsky E; Elkin M; Zcharia E; Peretz T; Vlodavsky I
    J Natl Cancer Inst; 2004 Aug; 96(16):1219-30. PubMed ID: 15316057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microfluidic devices for characterizing the agonist of formyl peptide receptor in RBL-FPR cells.
    Ye N; Wang MW; Qin J; Lin B
    Biomed Microdevices; 2010 Jun; 12(3):513-21. PubMed ID: 20195765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-formylpeptides induce two distinct concentration optima for mouse neutrophil chemotaxis by differential interaction with two N-formylpeptide receptor (FPR) subtypes. Molecular characterization of FPR2, a second mouse neutrophil FPR.
    Hartt JK; Barish G; Murphy PM; Gao JL
    J Exp Med; 1999 Sep; 190(5):741-7. PubMed ID: 10477558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.